Wheelers Books
Oxford Textbook of Oncology
 

Oxford Textbook of Oncology (Hardback, 3rd Revised edition)

Edited by Kerr, David J.
Edited by Haller, Daniel G.
Edited by Velde, Cornelius J. H. van de
Edited by Baumann, Michael
Edited by Saijo, Nagahiro

  • Imp. $1,353.50
  • $1,218.15
  • Save $135.35
  • No availability locally

Written by internationally recognised key opinion leaders in all of the oncology sub-disciplines and covering all aspects of the field, the Oxford Textbook of Oncology, Third Edition reflects current best practice and represents a modern approach to managing the cancer patient. T... read full description below.

ISBN 9780199656103
Barcode 9780199656103
Published 11 February 2016 by Oxford University Press (S1)
Format Hardback, 3rd Revised edition
Series Oxford Textbook
Availability
Internationally sourced; usually ships 2-3 weeks

... view full title details below.

Full details for this title

ISBN-13 9780199656103
ISBN-10 019965610X
Stock Available
Status Internationally sourced; usually ships 2-3 weeks
Publisher Oxford University Press (S1)
Imprint Oxford University Press
Publication Date 11 February 2016
International Publication Date 28 January 2016
Publication Country United Kingdom United Kingdom
Format Hardback, 3rd Revised edition
Edition 3rd Revised edition
Author(s) Edited by Kerr, David J.
Edited by Haller, Daniel G.
Edited by Velde, Cornelius J. H. van de
Edited by Baumann, Michael
Edited by Saijo, Nagahiro
Series Oxford Textbook
Category Oncology
Radiotherapy
Surgical Oncology
Number of Pages 1040
Dimensions Width: 227mm
Height: 282mm
Spine: 39mm
Weight 2,460g
Interest Age General Audience
Reading Age General Audience
Library of Congress Cancer, Oncology
NBS Text Clinical Medicine: Professional
ONIX Text Professional and scholarly
Dewey Code 616.994
Catalogue Code Not specified

Description of this Book

Written and edited by internationally recognised leaders in the field, the new edition of the Oxford Textbook of Oncology has been fully revised and updated, taking into consideration the advancements in each of the major therapeutic areas, and representing the multidisciplinary management of cancer. Structured in six sections, the book provides an accessible scientific basis to the key topics of oncology, examining how cancer cells grow and function, as well as discussing the aetiology of cancer, and the general principles governing modern approaches to oncology treatment. The book examines the challenges presented by the treatment of cancer on a larger scale within population groups, and the importance of recognising and supporting the needs of individual patients, both during and after treatment. A series of disease-oriented, case-based chapters, ranging from acute leukaemia to colon cancer, highlight the various approaches available for managing the cancer patient, including the translational application of cancer science in order to personalise treatment. The advice imparted in these cases has relevance worldwide, and reflects a modern approach to cancer care. The Oxford Textbook of Oncology provides a comprehensive account of the multiple aspects of best practice in the discipline, making it an indispensable resource for oncologists of all grades and subspecialty interests.

^ top

Awards, Reviews & Star Ratings

NZ Review Review from previous edition The Oxford Textbook of Oncology is a classic and fresh approach to the field. It is a must for all libraries and all those who like to have a single up-to-date reference book that contains sufficient detail for the clinician in all subspecialties: surgery and chapters are sufficiently details to provide a reference for trainees in the field. Oncology, Volume 63, 2002 The Oxford Textbook of Oncology covers virtually the entire spectrum of malignant diseases in adults and children. It meets very high editorial and production standards: the organization, illustrations, and eye-pleasing typography are outstanding... I have high praise for this textbook. NEJM, Volume 347, Number 2, 2002 Under new editorship, the second edition is far more than an updated version of the first...the prose in the Oxford Textbook is exemplary...this textbook is unique among its peers in giving the sense that the authors are addressing the reader personally...an exception level of qualityELRespect for the evidence-based medicine is apparent throughout the text...illustrative and anatomical drawing...of remarkable high quality...excellent discussion of doctor-patient communication in relation OT genetic counselling, psychological issues, and terminal cancers. JAMA, Volume 287, Issue 24, 2002 An outstanding work and an impressive achievement. Journal of the National Cancer Institute, 2002 A landmark referenceELIt sets new standards for publishing in oncology offering a ground-breaking innovative approach to the filed combined with the quality, accuracy , and intellectual rigour you have come to expect from the world's most prestigious reference publisher. Biomedicine and Pharmacotherapy, 2002 This comprehensive textbook of oncology is the first new major textbook on cancer to appear in a decade and is designed for a broad audience of clinicians, oncologists in training, and academics. The coverage is comprehensive...The overall appearance of the book is outstanding. It is a welcome combination of epidemiology, aspects of basic science, pharmacology and radiation therapy that trainees will fine a nice change...should enjoy a wide readership...because of its appealing design and comprehensive approach to oncology. It is the most user-friendly comprehensive text currently available. The pathology, basic science, epidemiology, and radiation therapy sections are all presented with extreme clarity. Doody's Journal , 2002 I recommend this book highly to all oncology and oncologists in training as a thorough, informative, and readable reference. Every large intuitional library and every oncology library should have it. NEJM, 2002
UK Review Bertrams Star Rating: 1 stars (out of 5)

^ top

Author's Bio

David Kerr has made a sustained and internationally recognised contribution to cancer care and research in the field of medical oncology over the past three decades. He has published over 400 papers in high profile journals, authored over twenty books and has been awarded four prestigious, international research prizes, including the NHS's first Nye Bevan award for Innovation. His scientific standing has been recognised by election as Fellow of the Royal College of Physicians, Fellow of Academy of Medical Sciences, President of the European society of Medical Oncology (2009-2011) and Founding Fellow of the European Academy of Cancer Sciences.

^ top